DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sanofi Consumer Healthcare India Limited — Board Meeting Intimation

NSE 1 hr ago·22 Oct 2026, 12:12 pm

Sanofi Cons Healthc IND L

Sanofi Consumer Healthcare India has announced that its Board of Directors will meet on October 28, 2026, to review and approve the company's unaudited financial results for the quarter ended September 2026. This is a standard procedural update where the board evaluates the firm's performance over the past three months.

For investors, this meeting is a key event as the results will reveal the company's current financial health, sales trends, and operational efficiency. Positive figures could signal strong market performance, while any misses might raise concerns about demand or margins. The announcement itself is a neutral update, but the subsequent release of the financial data is what will drive market sentiment.

Investors should watch for the official release of the results following the board meeting. The commentary from management regarding market conditions and future outlook will be crucial in determining the stock's short-term direction.